Sorafenib Induces Delayed-Onset Cutaneous Hypersensitivity: A Case Series

Sorafenib is an oral multikinase inhibitor with clinical activity against hepatocellular carcinoma (HCC) and renal cell carcinoma. Administration of sorafenib carries a variety of adverse cutaneous reactions. Common adverse effects induced by sorafenib include hand-foot skin reactions, facial erythe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Allergy Asthma Immunol Res
Autors principals: Sohn, Kyoung-hee, Oh, Soo-yeon, Lim, Kyung-Whan, Kim, Mi-Yeong, Lee, Suh-Young, Kang, Hye-Ryun
Format: Artigo
Idioma:Inglês
Publicat: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2015
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4397373/
https://ncbi.nlm.nih.gov/pubmed/25749785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4168/aair.2015.7.3.304
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars